Google’s Retrieve-for-Train research moves expensive search planning into training. The aim is a useful collection of results, delivered faster.
Agility’s next humanoid is designed to work close to people. Safe interruptions and predictable behavior will matter as much as lifting ability.
NVIDIA reports more AI output within a fixed power budget. The important distinction is between using capacity better and postponing work.
Selected · Four signals worth your attention.
More than 50 organizations launched the Pro-Human AI Coalition, co-founded by Project Liberty, the Future of Life Institute and Ergo Impact. The nonprofit will coordinate policy, research and technology efforts around human control of AI.
Georgia Power says its 128-megawatt Robins battery facility has entered commercial operation. Paired with nearby solar generation, it can supply stored electricity for up to four hours, shifting energy toward periods of higher demand.
Corteva confirmed a late-2027 launch for hybrid wheat made with Vylor’s Xpedite system. It reports higher yields in company trials, including under water stress; commercial performance across farms remains to be demonstrated.
Royalty Pharma announced a $7.5 million donation to Blood Cancer United’s Therapy Acceleration Program. The funding backs early-stage biotech investments and development support, with investment returns recycled into future blood-cancer therapies.
MatBrain narrowed 30,000 proposed structures to 38 candidates in 48 hours. Human researchers chose what to test. The useful question is how much work that shortlist saves.
A bigger quantum computer can still fail at the calculation that matters. QUOPS and CUDA-Q Logical offer clearer ways to judge what a machine can do.
Two people with paralysis used brain signals to display words and animate an avatar’s gestures. The experiment opens a bigger question: how much control does the person have over what the screen expresses?
Trump rejects the AI slowdown as China challenges its terms. Behind the clash lies a harder question: who controls a race that may begin accelerating itself?
Gotistobart's new lung-cancer data are striking. Its real test is whether molecular precision can produce a repeatable survival benefit.
Skild and Generalist are making robots faster to teach. Their results reveal why learning a task and delivering reliable work are different engineering problems.
Seven fields. A clear place to begin.
Selected stories about what changes for us.
Technology and science, with the evidence and consequences explained.
Occasional editions. Free to subscribe.
Unsubscribe anytime.
